Breast sarcomas: Current and future perspectives
Authors:
- Ioannis A. VoutsadakisIVIoannis A. Voutsadakis
- Khalil ZamanKZKhalil Zaman
- Serge LeyvrazSLSerge Leyvraz
Open Access
- 1 June 2011
- journal article
- review article
- Published by Elsevier in The Breast
- Vol. 20 (3) , 199-204
Abstract
No abstract availableKeywords
This publication has 66 references indexed in Scilit:
- Safety, pharmacokinetics, and preliminary activity of the anti-IGF-1R antibody figitumumab (CP-751,871) in patients with sarcoma and Ewing's sarcoma: a phase 1 expansion cohort studyThe Lancet Oncology, 2010
- Sarcomes en territoire irradié : actualitésCancer/Radiothérapie, 2010
- Postirradiation Sarcoma: Clinicopathologic Features and Role of Chemotherapy in the Treatment StrategySarcoma, 2009
- KDR Activating Mutations in Human Angiosarcomas Are Sensitive to Specific Kinase InhibitorsCancer Research, 2009
- Primary retroperitoneal myxoid/round cell liposarcoma is a nonexisting disease: an immunohistochemical and molecular biological analysisLaboratory Investigation, 2009
- Angiosarcoma of the breast: the experience of the European Institute of Oncology and a review of the literatureBreast Cancer Research and Treatment, 2006
- Radiation‐induced sarcomas after radiotherapy for breast carcinomaCancer, 2005
- Primary sarcoma of the breastJournal of Surgical Oncology, 2004
- Primary breast sarcoma: clinicopathologic series from the Mayo Clinic and review of the literatureBritish Journal of Cancer, 2004
- SYT–SSXGene Fusion as a Determinant of Morphology and Prognosis in Synovial SarcomaNew England Journal of Medicine, 1998